Amicus Therapeutics (FOLD) Tops Q4 EPS by 8c
Tweet
Share
E-mail
Get Alerts FOLD Hot Sheet
Join SI Premium – FREE
Amicus Therapeutics (NASDAQ: FOLD) reported Q4 EPS of $0.09, $0.08 better than the analyst estimate of $0.01.
For earnings history and earnings-related data on Amicus Therapeutics (FOLD) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Trump said he was unaware of his earnings from crypto
- Crusoe in talks to raise $3B in funding - Bloomberg
- JPMorgan Upgrades Nanya Technology Corp (2408:TT) to Overweight
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
